Showing 951-960 of 5805 results for "".
The Skin After Cancer
https://practicaldermatology.com/topics/general-topics/the-skin-after-cancer/20797/There are lots of questions, but still few answers. Here's what we know.Considering Selling Your Practice? Here's What You'll Need to Share
https://practicaldermatology.com/topics/practice-management/considering-selling-your-practice-heres-what-youll-need-to-share/20320/There can be no secrets in negotiations to sell a practice. Even if the other side is inadequate in their due diligence, you have to be cognizant of lawsuits for fraud if misrepresentation ever comes to light. Here's what to think about before initiating a dialogue.NPF Services, Eskata Update, AAD Meeting Data
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-npf-services-eskata-update-aad-meeting-data/18326/The National Psoriasis Foundation is expanding its services to patients, with a special focus on teens affected by the Skin Disease. Widely anticipated by both physicians and patients, Eskata will be available for in-office use this spring. Aclaris CEO, Dr. Neal Walker addresses the launch, as wellAttention, Please! Why Dermatologists Need to Confront Burnout
https://practicaldermatology.com/topics/practice-management/attention-please-why-dermatologists-need-to-confront-burnout/20557/Raising awareness of the problem is essential to finding a solution.Guiding Patients to Good Skincare
https://practicaldermatology.com/topics/practice-management/guiding-patients-to-good-skincare/20577/A skincare pyramid offers physicians a tool to engage and educate patients about anti-aging skincare options from prevention to reversal.How Much Are You Paying Your Advisor?
https://practicaldermatology.com/topics/practice-management/how-much-are-you-paying-your-advisor/20609/A guide to understanding advisor fees and other charges.eRelevance Uncovers Marketing Truths, EADV Data, Primetime for Botox
https://practicaldermatology.com/series/dermwire-tv/erelevance-uncovers-marketing-truths-eadv-data-primetime-for-botox/18429/The State of Aesthetic Healthcare Marketing 2017 from eRelevance shows that nearly 60 percent of aesthetic physicians say they either don't see results from their marketing initiatives or aren't able to measure results. Data presented at the annual meeting of the European Academy of Dermatology andIs Your Dermatology Website Ready to Go Mobile?
https://practicaldermatology.com/topics/practice-management/go-mobile/18440/Know best practices for creating a mobile-friendly websites and preparing for Google's Mobile First index. Since 2015 mobile search has outpaced desktop search, and the gap is widening. Know what you need to succeed in this Ekwa.com Marketing Educational video.Pearls for Treating Skin Cancer
https://practicaldermatology.com/topics/general-topics/pearls-for-treating-skin-cancer/18446/When should you treat basal cell carcinomas with adjuvant therapies before excising? Why is the number two important to remember when treating squamous cell carcinoma? Is Merkel cell carcinoma on the rise? Gary Goldenberg, MD answers these questions and offers an update on the newest therapies and bRe-introducing Ortho Dermatologics, Tremfya Approved, Obagi Acquired
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-re-introducing-ortho-dermatologics-tremfya-approved-obagi-acquired/18458/Valeant Pharmaceuticals is changing the name of its dermatology division to Ortho Dermatologics. In an exclusive interview with DermWireTV, Executive Vice President and dermatology industry veteran William Bill Humphries discusses the change. The FDA has approved Janssen Biotech's Tremfya (guselkuma